If you enjoy this content, please share it with a colleague
RELATED CONTENT
Five global MRI manufacturers—in the United States, Europe and Asia—have selected ContextVision’s GOPView MRI2Plus to upgrade their MRI equipment. Today’s healthcare industry requires improved efficiencies without sacrificing patient safety. As radiologists around the world review an increasing number of MRI images every day, image quality is key.
ContextVision released another ultrasound product for the mid-end ultrasound segment; a new version of the image enhancement software US PlusView was designed for the digital signal processor (DSP).
At RSNA 2013, ContextVision will announce its latest additions to its U.S. PlusView Family, which will include four different packages for women’s health, general imaging, cardiovascular and point of care (POC). More anatomically correct images provide medical professionals diagnostic confidence for the most complex patient cases.
Sapheneia Commercial Products AB filed for bankruptcy Aug. 28, 2013. Shortly before the company went into bankruptcy, it changed its company name to “Contact Imaging Sweden AB.” In July 2013, the Stockholm District Court ruled that ContextVision is the real owner of a key patent application filed by Sapheneia in September 2006. The court also ruled that Sapheneia should pay the legal costs of ContextVision amounting to TSEK 2,940. The amount has not been paid, and instead, Sapheneia filed for bankruptcy. The administration of the company in bankruptcy has been taken over by a receiver.
The Stockholm District Court ruled ContextVision is the owner of a patent application filed by Sapheneia in September 2006. The patent application represents the underlying technology across multiple medical imaging modalities. ContextVision proved that the technology within the patent is a result of work the two filing inventors conducted during their time at ContextVision.
The imaging industry continues to face challenges with technically difficult patients, while demand for more accurate images continues to rise. ContextVision will address these trends and demonstrate its 2-D/3-D/4-D ultrasound image enhancement capabilities at the American Institute of Ultrasound in Medicine (AIUM).
November 19, 2012 – Since 1983, ContextVision has pushed its image enhancement technology forward, delivering unparalleled diagnostic image quality to clinicians. At RSNA this year, ContextVision will demonstrate its cutting-edge software within ultrasound, x-ray, magnetic resonance imaging, mammography and more.
June 1, 2012 — Through the rapid growth of multi-slice computer tomography (CT) imaging, radiation protection has become a major issue in the radiological community. In response to this problem, ContextVision has collaborated with Dr. Lars Borgen, Drammen and Buskerud University College, Drammen, Norway, to explore technology solutions that will deliver superior image enhancement in cases of reduced patient image doses. Today Borgen will present his thesis, “Application of Adaptive Non-Linear 2-D and 3-D Post-Processing Filters for Reduced Dose Abdominal CT.”
September 14, 2011 - ContextVision announced a new advanced imaging capability for its ultrasound image enhancement software product family, USPLUSView and GOPiCE US, directed towards the technically difficult maternity patient. The new technology, Clinical Direct Focused Enhancement (DFE) enables feature/region specific enhancement, a first in the original equipment manufacturer (OEM) market. US PLUSView allows OEMs to provide a full range of ultrasound image enhancement capabilities, including deeper penetration, edge sharpening, contrast enhancement and improved speckle reduction features.
The last couple of years in the United States and Europe have seen an increased focus on the cumulative patient dose received from a wide variety of X-ray devices including classical X-ray, computed tomography (CT), interventional radiology and mammography. The deleterious effects of radiation dose have received widespread coverage, and the partial answer has been a movement towards non-ionizing diagnostic imaging equipment, such as magnetic resonance imaging (MRI) and ultrasound.